• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up2.27% Nasdaq Up2.45%

    Esperion Therapeutics, Inc. (ESPR)

    -NasdaqGM
    52.01 Down 0.84(1.59%) 4:00PM EDT
    |After Hours : 53.45 Up 1.44 (2.77%) 6:57PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development25,302  16,014  7,998  
    Selling General and Administrative10,922  6,745  2,206  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (36,224) (22,759) (10,204)
    Income from Continuing Operations
    Total Other Income/Expenses Net119  (2,393)(52)
    Earnings Before Interest And Taxes(36,105)(25,152)(10,256)
    Interest Expense270  936  1,486  
    Income Before Tax(36,375)(26,088)(11,742)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(36,375)(26,088)(11,742)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (36,375) (26,088) (11,742)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (36,375) (26,088) (11,742)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.